IP Library Granted Patent US 11,066,682
Granted Patent B2
US 11,066,682 · App. 14/007,857 · Granted Jul 20, 2021

Methods and compositions for improved production of fatty acids and derivatives thereof

Inventors: Derek L. Greenfield (South San Francisco, CA); Louis G. Hom (San Carlos, CA); Fernando A. Sanchez-Riera (South San Francisco, CA); Zhihao Hu (Castro Valley, CA); Vikranth Arlagadda (San Bruno, CA); Eli S. Groban (San Francisco, CA); Scott A. Frykman (San Francisco, CA)
Assignee: Genomatica, Inc.
C12P7/6409C07C31/125C07C33/02C07C53/126C07K14/195C07K14/245Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,066,682
App. No.
14/007,857
Granted
Jul 20, 2021
Kind
B2
Abstract

The invention relates to compositions and methods, including polynucleotide sequences, amino acid sequences, and engineered host cells for producing fatty acids and derivates of fatty acids such as acyl-CoA, terminal olefins, fatty aldehydes, fatty alcohols, alkanes, alkenes, wax esters, ketones and internal olefins through altered expression of the transcription factor, fadR.

Claims (24)

1. A method of producing a fatty acid, fatty acid ester, fatty aldehyde or a fatty alcohol, the method comprising:

(a) providing a host cell which is genetically engineered to have an increased level of expression of FadR polypeptide comprising the amino acid sequence of SEQ ID NO:1, optionally comprising a mutation at the amino acid residue serine 219 of SEQ ID NO:1 which is substituted by asparagine, compared to corresponding wild-type host cell, wherein the engineered host cell is a bacterial cell,

(b) culturing the engineered host cell in a culture medium comprising a carbohydrate carbon source under conditions permissive for the production of the fatty acid, fatty acid ester, fatty aldehyde or the fatty alcohol, and

(c) isolating the fatty acid, fatty acid ester, fatty aldehyde or the fatty alcohol, from the engineered host cell, wherein the engineered host cell produces 15% or more total fatty acid species compared to corresponding wild-type host cell under the same cultivation condition, wherein the fatty acid species are the fatty acid, fatty acid ester, fatty aldehyde and/or fatty alcohol.

2. The method of claim 1 , wherein the FadR polypeptide comprises the mutation which is a substitution of the amino acid 219 of SEQ D NO:1 with an asparagine residue.

3. The method of claim 1 , wherein the expression level of the FadR polypeptide in the engineered host cell is regulated by an exogenous element comprising an expression control sequence operably linked to the gene encoding the FadR polypeptide in said genetically engineered host cell.

4. The method of claim 3 , wherein the expression control sequence is a promoter.

5. The method of claim 3 , wherein the expression control sequence is a ribosome binding site.

6. The method of claim 1 , wherein the engineered host cell further comprises an altered level of expression of one or more gene selected from the group consisting of fabA, fabB, iclR, fadA, fadB, fadD, fadE, fadI, fadJ, fadL, fadM, uspA, aceA, aceB, and aceK as compared to the level of expression of the selected gene in a corresponding wild-type host cell.

7. The method of claim 1 , wherein the fatty acid ester is a fatty acid methyl ester (FAME) or a fatty acid ethyl ester (FAEE).

8. The method of claim 1 , wherein an ester synthase is expressed in the engineered host cell at a greater concentration than is normally expressed in a corresponding wild-type cell under the same conditions.

9. The method of claim 8 , wherein the ester synthase is ES9 from Marinobacter hydrocarbonoclasticus (SEQ ID NO: 2), ES8 from Marinobacter hydrocarbonoclasticus (SEQ ID NO: 3), AtfA1 fromAlcanivorax borkumensis SK2 (SEQ ID NO: 4), AtfA2 from Alcanivorax borkumensis SK2 (SEQ ID NO: 5), diacylglycerol O-acyltransferase from Marinobacter aquaeolei VT8 (SEQ ID NO: 6 or SEQ ID NO: 7), a wax synthase, or a bifunctional wax ester synthase/acyl-CoA:diacylglycerol acyltransferase (wax-dgaT).

10. The method of claim 1 , wherein an acetyl-CoA carboxylase complex is overexpressed in the engineered host cell.

11. The method of claim 10 , wherein the acetyl-CoA carboxylase complex is encoded by two or more acetyl-CoA carboxylase subunit genes obtained from one or more of Corynebacterium glutamicum, Escherichia coli, Lactococcus lactis, Kineococcus radiotolerans, Desulfovibrio desulfuricans, Erwinia amylovora, Rhodospirillum rubrum, Vibrio furnissii, Stenotrophomonas maltophilia, Synechocystis sp. PCC6803, or Synechococcus elongatus.

12. The method of claim 10 , wherein a biotin protein ligase is overexpressed in the engineered host cell.

13. The method of claim 1 , wherein a carboxylic acid reductase and a thioesterase are overexpressed in the engineered host cell.

14. The method of claim 13 , wherein an alcohol dehydrogenase 1s overexpressed in the engineered host cell.

15. The method of claim 14 , wherein the carboxylic acid reductase is carB (SEQ ID NO: 8), the thioesterase is tesA (SEQ ID NO: 11) and the alcohol dehydrogenase is YjgB (SEQ ID NO: 10) or AlrAadpl (SEQ ID NO: 9).

16. The method of claim 15 , wherein a phosphopanthetheinyl transferase (PPTase) is overexpressed in the engineered host cell.

17. The method of claim 16 , wherein the PPTase is EntD from E. coli MG1655 (SEQ ID NO: 12).

18. The method of claim 1 , wherein the bacterial cell is selected from the group consisting of an E. coli cell, a Bacillus lentus cell, a Bacillus brevis cell, a Bacillus stearothermophilus cell, a Bacillus lichen formis cell, a Bacillus alkalophilus cell, a Bacillus coagulans cell, a Bacillus circulans cell, a Bacillus pumilis cell, a Bacillus thuringiensis cell, a Bacillus clausii cell, a Bacillus megaterium cell, a Bacillus subtilis cell, and a Bacillus amyloliquefaciens cell.

19. A fatty alcohol produced by the method of claim 1 which is a C6, C8, C10, C12, C13, C14, C15, C16, C17, or C18 fatty alcohol.

20. The fatty alcohol of claim 19 , wherein the fatty alcohol is a C10:1, C2:1, C4:1, C6:1, or C8:1 unsaturated fatty alcohol.

21. A surfactant composition comprising the fatty alcohol of claim 19 .

Assignments (7)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE A, LINE 221 PREVIOUSLY RECORDED ON REEL 034193 FRAME 0175. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT APPLICATION NUMBER. Recorded Apr 7, 2015
From: LS9, INC.
To: REG LIFE SCIENCES, LLC
Reel/Frame 035391/0384 →
AMENDMENT TO PATENT ASSIGNMENT Recorded Nov 7, 2014
From: LS9, INC.
To: REG LIFE SCIENCES, LLC
Reel/Frame 034193/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2014
From: GREENFIELD, DEREK L.; HOM, LOUIS G.; SANCHEZ-RIERA, FERNANDO; HU, ZHIHAO; ARLAGADDA, VIKRANTH; GROBAN, ELI; FRYKMAN, SCOTT A.
To: LS9, INC.
Reel/Frame 032022/0461 →
Continuity (2)
Provisional Application 61470989 · Apr 1, 2011
Related Publication 20140179940A1 · Jun 26, 2014